| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,776 |
Net Tangible Asset Backing
|
31 Jul 2025 8:25AM |
$3.110 |
$4.380 |
risen by
40.84%
|
|
| NT Minerals Limited (NTM) ORDINARY FULLY PAID |
Materials |
$4 |
Quarterly Activities Report - June 2025
|
31 Jul 2025 8:25AM |
$0.002 |
$0.003 |
risen by
50%
|
|
NTM - Price-sensitive ASX Announcement
Full Release
Key Points
- Ongoing exploration activities at the Redbank Copper Project in Northern Territory, Australia.
- Resource drilling programs continue with encouraging results supporting resource expansion.
- Metallurgical test work and environmental baseline studies have advanced during the quarter.
- Stakeholder engagement remains a focus, including with Traditional Owners and government authorities.
- Quarterly expenditures and cash position reported, outlining financial discipline and exploration investment.
- Planned future activities include further drilling, studies, and project development work.
- Safety performance, environmental management, and regulatory compliance emphasized throughout operations.
- The company provides updates on tenement status and forward-looking guidance for shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Berkeley Energia Limited (BKY) ORDINARY FULLY PAID |
Energy |
$170 |
Quarterly Report June 2025
|
31 Jul 2025 8:25AM |
$0.530 |
$0.380 |
fallen by
28.30%
|
|
BKY - Price-sensitive ASX Announcement
Full Release
Key Points
- Berkeley Energia Limited's main focus remains on the Salamanca Project in Spain.
- The company faces ongoing regulatory and permitting challenges with Spanish authorities.
- Berkeley is engaging with government agencies to resolve outstanding issues related to project approval.
- Financial updates include details on cash flow, project expenditures, and capital management.
- Commitment to ESG standards and practices is emphasized, with updates on related initiatives.
- Risk management strategies are outlined to address operational and market uncertainties.
- The report includes forward-looking statements on the uranium market and company outlook.
- Corporate governance policies and board activities are covered in the period.
- The company continues to assess strategic options to maximize shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Red Hill Minerals Limited (RHI) ORDINARY FULLY PAID |
Materials |
$308 |
Quarterly Activities, Tenements and App5B Cash Flow Report
|
31 Jul 2025 8:24AM |
$3.450 |
$4.800 |
risen by
39.13%
|
|
RHI - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers activities up to March 31, 2024.
- Ongoing work on Red Hill Iron Ore Joint Venture (RHIOJV) including feasibility and permitting.
- Update on exploration activities for iron ore and gold projects.
- Details of cash flow for the quarter, with expenditures on exploration and administration.
- Strong financial position maintained through prudent cash management.
- Engagement with joint venture partner and stakeholders continues.
- Commitment to achieving project milestones and maximizing shareholder value.
- No mining production or development during the quarter, focus is on advancement and study work.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sovereign Metals Limited (SVM) ORDINARY FULLY PAID |
Materials |
$446 |
June 2025 Quarterly Report
|
31 Jul 2025 8:24AM |
$0.715 |
$0.680 |
fallen by
4.90%
|
|
SVM - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant progress on the Kasiya Rutile-Graphite Project in Malawi during the June 2025 quarter.
- Advancement of feasibility studies and environmental baseline assessments.
- Ongoing community engagement and social responsibility initiatives.
- Strong financial position and active pursuit of strategic partnerships.
- Resource definition and expansion activities continued with positive results.
- Focus on project funding strategies and shareholder value delivery.
- Commitment to sustainable and responsible mining practices.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$6,921 |
Notice of H1 2025 Results Presentation
|
31 Jul 2025 8:23AM |
$5.220 |
$4.770 |
fallen by
8.62%
|
|
| Nexion Group Ltd (NNG) ORDINARY FULLY PAID |
Information Technology |
- |
NNG Quarterly Activities Report and Appendix 4C Jun-25
|
31 Jul 2025 8:23AM |
$0.020 |
$0.020 |
fallen by
0%
|
|
| ImpediMed Limited (IPD) ORDINARY FULLY PAID |
Health Care |
$19 |
Investor Presentation
|
31 Jul 2025 8:23AM |
$0.052 |
$0.008 |
fallen by
84.62%
|
|
| ImpediMed Limited (IPD) ORDINARY FULLY PAID |
Health Care |
$19 |
Quarterly Activities Report and Appendix 4C - Jun-2025 Qtr
|
31 Jul 2025 8:23AM |
$0.052 |
$0.008 |
fallen by
84.62%
|
|
IPD - Price-sensitive ASX Announcement
Full Release
Key Points
- SOZO platform continues to gain commercial traction with increased adoption across clinical settings.
- Significant progress in lymphedema prevention initiatives, supported by expanding clinical data.
- Financial update shows cash receipts, expenditures, and a focus on managing cash runway.
- New US reimbursement codes positively impact commercial prospects and revenue streams.
- PREVENT clinical trial remains central to company strategy, influencing guidelines and payer coverage decisions.
- Ongoing strategic initiatives to drive growth, including partnerships and increased physician engagement.
- Regulatory and reimbursement environment is favorable, with updates on payer coverage and coding.
- Continued investment in clinical evidence to support market adoption and reinforce the value proposition.
- Appendix 4C details cash flows and projected funding for future operations.
- Board and management remain focused on executing long-term strategy and delivering value to shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| RBR Group Limited (RBR) ORDINARY FULLY PAID |
Materials |
$3 |
Board and Corporate Update
|
31 Jul 2025 8:22AM |
$0.001 |
$0.020 |
risen by
1,900%
|
|
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$98 |
Completion of Galidesivir transaction
|
31 Jul 2025 8:22AM |
$0.170 |
$0.330 |
risen by
94.12%
|
|
ILA - Price-sensitive ASX Announcement
Full Release
Key Points
- Island Pharmaceuticals completed the acquisition of Galidesivir from BioCryst Pharmaceuticals.
- Galidesivir is a clinical-stage broad-spectrum antiviral with potential applications for dengue and other viral diseases.
- The transaction includes all rights, intellectual property, and supporting data for Galidesivir.
- The acquisition strengthens Island Pharmaceuticals' pipeline and presence in antiviral therapeutics.
- Island Pharmaceuticals plans to further develop Galidesivir and seek development partnerships.
- The completion of the transaction aligns with the company's strategic growth objectives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Estrella Resources Limited (ESR) ORDINARY FULLY PAID |
Materials |
$80 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 8:22AM |
$0.039 |
$0.036 |
fallen by
7.69%
|
|
ESR - Price-sensitive ASX Announcement
Full Release
Key Points
- Estrella Resources Limited completed the T5 Resource Drilling Program at the Carr Boyd Nickel Project.
- Initial work commenced on a maiden JORC compliant mineral resource estimate for the T5 discovery.
- Metallurgical test work on nickel sulphide mineralisation was undertaken with positive preliminary results.
- Studies for processing options to unlock project value are ongoing.
- The company continues to evaluate and review new resource opportunities.
- Ongoing engagement with strategic partners and stakeholders.
- Quarterly cash flow report (Appendix 5B) details expenditure and financial position.
- The company remains focused on advancing the Carr Boyd Nickel Project as its main asset.
- No significant production or revenue generated during the quarter.
- Corporate activities included investor engagement and project advancement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| RBR Group Limited (RBR) ORDINARY FULLY PAID |
Materials |
$3 |
Initial Director's Interest Notice
|
31 Jul 2025 8:22AM |
$0.001 |
$0.020 |
risen by
1,900%
|
|
| Juno Minerals Limited (JNO) ORDINARY FULLY PAID |
Materials |
$6 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 8:22AM |
$0.025 |
$0.027 |
risen by
8%
|
|
JNO - Price-sensitive ASX Announcement
Full Release
Key Points
- Juno Minerals Limited released its Quarterly Activities/Appendix 5B Cash Flow Report for Q1 2024.
- Focus remained on advancing the Mount Mason DSO Hematite Project.
- Progress made in securing land access agreements and environmental/heritage approvals.
- No mining or processing activities commenced during the quarter.
- Company maintained a strong cash position of $2.6 million.
- Cost management measures continued to be implemented.
- Juno is reviewing new project opportunities.
- Commitment to iron ore project development in the Yilgarn region of Western Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| RBR Group Limited (RBR) ORDINARY FULLY PAID |
Materials |
$3 |
Final Director's Interest Notice
|
31 Jul 2025 8:21AM |
$0.001 |
$0.020 |
risen by
1,900%
|
|
| Battery Age Minerals Ltd (BM8) ORDINARY FULLY PAID |
Materials |
$16 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 8:21AM |
$0.073 |
$0.070 |
fallen by
4.11%
|
|
BM8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Commenced 20,000m multi-rig drilling at Falcon Lake Lithium Project in Canada targeting high-priority pegmatite zones
- Early drilling assays at Falcon Lake confirm high-grade lithium mineralization
- Advanced exploration activities at the Bleiberg Zinc-Lead Project in Austria
- Continued assessment of strategic acquisitions and partnership opportunities
- Closing cash balance of approximately A$9.6 million at the end of the quarter
- Expenditures primarily allocated to exploration and evaluation activities
- No significant mining production or project development reported during the quarter
- Company remains well-funded to pursue ongoing exploration programs
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Knosys Limited (KNO) ORDINARY FULLY PAID |
Information Technology |
$5 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 8:20AM |
$0.037 |
$0.022 |
fallen by
40.54%
|
|
KNO - Price-sensitive ASX Announcement
Full Release
Key Points
- Knosys achieved growth in SaaS platform customer base during the quarter.
- Secured a significant contract extension with an Australian federal government agency.
- Won new customers in the health and wellness sector.
- Focused on expanding presence in the Asia-Pacific region.
- Increased investment in product development and innovation.
- Cash receipts from customers rose compared to the previous quarter.
- Net operating cash outflow decreased, reflecting improved financial management.
- Detailed cash flow figures provided in Appendix 4C.
- Plans to continue investment in sales, marketing, and product innovation.
- Strategy includes targeting new industry verticals for further growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| FireFly Metals Ltd (FFM) ORDINARY FULLY PAID |
Materials |
$1,684 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 8:20AM |
$1.085 |
$2.190 |
risen by
101.84%
|
|
FFM - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant maiden resource drilling success at Greenlight and Wills prospects within the Greenlight Copper-Gold Project in WA.
- Strong copper and gold mineralisation intersected, supporting a maiden Mineral Resource Estimate in Q2 2024.
- Exploration advances at the Yalco Project in NT, with preparations for drilling new targets.
- Successful capital raising completed, bolstering the company’s cash position.
- Quarterly cash flow primarily allocated to exploration and evaluation activities.
- Financial summary in Appendix 5B shows robust cash position as at 31 March 2024.
- Outlook includes continued exploration, resource estimation, and project development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Black Dragon Gold Corp (BDG) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
- |
Quarterly Report & Cashflow
|
31 Jul 2025 8:20AM |
$0.070 |
$0.086 |
risen by
22.86%
|
|
BDG - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report for the period ending 31 March 2024
- Focus on Salave Gold Project in Asturias, Spain
- Progress in permitting and environmental impact studies
- Active engagement with local communities and stakeholders
- Updates on exploration and development activities
- Detailed cashflow statement showing exploration and administrative outflows
- Company maintains sufficient cash reserves for ongoing activities
- Discussion of funding strategies for future project milestones
- Outline of priorities for the next quarter including advancing permitting and technical studies
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Percheron Therapeutics Limited (PER) ORDINARY FULLY PAID |
Health Care |
$6 |
Quarterly Activities Report and Appendix 4C
|
31 Jul 2025 8:20AM |
$0.009 |
$0.004 |
fallen by
55.56%
|
|
PER - Price-sensitive ASX Announcement
Full Release
Key Points
- Advanced development of MTP-131 for rare mitochondrial diseases.
- Continued progress in preclinical and clinical programs.
- Maintained a cash balance of $5.6 million at quarter-end.
- Adhered to operational budgets and financial discipline.
- No significant structural changes to the business during the quarter.
- Ongoing engagement with stakeholders and regulatory bodies.
- Updates on research milestones and future outlook included.
- Quarterly Activities Report and Appendix 4C released for period ending 31 March 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Peppermint Innovation Limited (PIL) ORDINARY FULLY PAID |
Information Technology |
$13 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 8:20AM |
$0.002 |
$0.004 |
risen by
100%
|
|
PIL - Price-sensitive ASX Announcement
Full Release
Key Points
- Peppermint Innovation Limited continued its focus on expanding fintech services in the Philippines.
- The bizmoto platform experienced ongoing growth and development, with emphasis on digital financial services and micro-enterprise lending.
- Loan disbursements through bizmoPay continued, supporting small business clients.
- The company progressed discussions and plans to obtain digital banking licenses.
- Efforts were made to expand the customer base and engage new agents and business partners.
- The financial report (Appendix 4C) details cash flows, receipts, and expenditure for the quarter.
- Peppermint Innovation Limited is exploring additional business growth opportunities and technology integrations.
- Operational highlights include continued regulatory compliance and focus on sustainable growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Teaminvest Private Group Limited (TIP) ORDINARY FULLY PAID |
Financials |
$32 |
Update - Notification of buy-back - TIP
|
31 Jul 2025 8:20AM |
$1.720 |
$1.190 |
fallen by
30.81%
|
|
| Dubber Corporation Limited (DUB) ORDINARY FULLY PAID |
Information Technology |
$27 |
Q4 FY25 Quarterly Activities Report and Appendix 4C
|
31 Jul 2025 8:20AM |
$0.022 |
$0.010 |
fallen by
54.55%
|
|
DUB - Price-sensitive ASX Announcement
Full Release
Key Points
- Achieved first positive net operating cashflow quarter.
- Operating revenues increased in Q4 FY25.
- Significant reduction in costs and improved operational efficiency.
- Growth in Unified Call Recording (UCR) and AI voice data services.
- Secured new partnerships and customer contracts.
- Continued global platform expansion and scalability.
- Ongoing investment in AI-enabled voice data product development.
- Appendix 4C details receipts, expenditures, and cash position.
- Management commentary outlines strategy for further growth and profitability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nex Metals Exploration Limited (NME) ORDINARY FULLY PAID |
Materials |
$6 |
NME June Activities-cashflow
|
31 Jul 2025 8:20AM |
$0.022 |
$0.018 |
fallen by
18.18%
|
|
NME - Price-sensitive ASX Announcement
Full Release
Key Points
- NME continued work on its flagship Kookynie and Yundamindra gold projects.
- The company reported minimal on-ground exploration due to financial constraints.
- Legal proceedings with Metalicity Limited regarding disputed joint venture arrangements remain ongoing.
- Efforts were ongoing to secure funding and potential new joint venture partners.
- NME provided a summary of its cashflow, noting limited expenditure and related party payments.
- The company addressed ASX compliance, including responses to queries and disclosure obligations.
- NME’s securities remain suspended from quotation pending resolution of outstanding issues.
- No production or development activities were reported during the period.
- The company is reviewing asset development options and potential for future exploration.
- NME outlined risks and uncertainties relating to funding and litigation outcomes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Yugo Metals Limited (YUG) ORDINARY FULLY PAID |
Materials |
$32 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 8:20AM |
$0.034 |
$0.090 |
risen by
164.71%
|
|
YUG - Price-sensitive ASX Announcement
Full Release
Key Points
- Yugo Metals Limited released its Quarterly Activities and Appendix 5B Cash Flow Report for Q1 2024.
- Significant progress was made at the Boulbi Project in Niger, focusing on permitting and technical studies.
- Exploration activities were conducted on Australian tenements, advancing the company’s critical minerals portfolio.
- Stakeholder engagement and government liaison remain key priorities for project development.
- The company reported cash outflows primarily for exploration and corporate costs, maintaining a healthy cash position.
- Financial management and capital allocation are being closely monitored to support ongoing and future projects.
- Yugo Metals continues to focus on advancing its portfolio of critical minerals projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
